Pharming (PHAR) EBT Margin (2020 - 2025)
Historic EBT Margin for Pharming (PHAR) over the last 6 years, with Q3 2025 value amounting to 125.69%.
- Pharming's EBT Margin rose 1202000.0% to 125.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.04%, marking a year-over-year increase of 138900.0%. This contributed to the annual value of 2.9% for FY2024, which is 7000.0% down from last year.
- Latest data reveals that Pharming reported EBT Margin of 125.69% as of Q3 2025, which was up 1202000.0% from 2.21% recorded in Q2 2025.
- Pharming's 5-year EBT Margin high stood at 484.88% for Q1 2022, and its period low was 29.35% during Q1 2024.
- For the 5-year period, Pharming's EBT Margin averaged around 33.46%, with its median value being 1.1% (2021).
- Per our database at Business Quant, Pharming's EBT Margin surged by 4848800bps in 2022 and then plummeted by -526700bps in 2023.
- Over the past 5 years, Pharming's EBT Margin (Quarter) stood at 13.73% in 2021, then crashed by -44bps to 7.75% in 2022, then plummeted by -186bps to 6.63% in 2023, then crashed by -40bps to 9.3% in 2024, then skyrocketed by 1451bps to 125.69% in 2025.
- Its EBT Margin stands at 125.69% for Q3 2025, versus 2.21% for Q2 2025 and 8.91% for Q1 2025.